MEDIPOST signed a MOU on mutual cooperation and support in stem cell research with CCRM (Center for Commercialization of Regenerative Medicine), a Canadian public-private consortium funded by the Government of Canada.

The MOU signing ceremony was held on December 1 in Seoul in attendance of CCRM CEO Michael H. May, Premier of Ontario, Kathleen Wynne and Canadian Ambassador to South Korea Eric Walsh.

With this MOU, MEDIPOST expects to receive support and benefits when conducting clinical trials and acquiring sales license and registering insurance entering the Canadian stem cell drug market.